PD21: Prostate Cancer: Epidemiology & Natural History I

Podium Session Moderator(s)

• 

  Jaime Cajigas, MD

  CLINICA DE MARLY
• CK

  Christopher Kane, MD

  University of California San Diego
• 

  Ashley Ross, MD, PHD

  Northwestern Feinberg School of Medicine

Presentations:

• 1:00 PM – 1:10 PM CST

  PD21-01: The Association between the Herbicide 2,4-D and Prostate Cancer among U.S. Men
  

  Podium Presenter: Frank Glover, III, PhD
• 1:10 PM – 1:20 PM CST

  PD21-02: Assessing the generalizability of randomized evidence by comparing results from a clinical trial and established quality improvement collaborative: results from G-MINOR and MUSIC
  

  Podium Presenter: Udit Singhal, MD
• 1:20 PM – 1:30 PM CST

  PD21-04: The Impact of Neighborhood Deprivation and Race on Prostate Cancer-Specific Mortality for Wisconsin Men
  

  Podium Presenter: Arighno Das, MD
• 1:30 PM – 1:40 PM CST

  PD21-05: Cardiovascular Outcomes in a Population-based Cohort of Prostate Cancer Patients
  

  Podium Presenter: Siqi Hu
• 1:40 PM – 1:50 PM CST

  PD21-06: Oncological outcomes in immunocompromised vs immunocompetent prostate cancer patients: a Systematic review and Meta-Analysis
  

  Podium Presenter: Andrea Gallioli, MD (he/him/his)
• 1:50 PM – 2:00 PM CST

  PD21-07: Racial impact (Asian vs. White) on the prognosis of patients with de novo mCSPC: An analysis on LATITUDE, SEER and NCDB.
  

  Podium Presenter: XuDong Ni
• 2:00 PM – 2:10 PM CST

  PD21-08: Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
  

  Podium Presenter: Nicholas Deebel, MD
• 2:10 PM – 2:20 PM CST

  PD21-09: Genomic Alterations in United States Veterans with Metastatic Prostate Cancer and Self-Reported Agent Orange Exposure
  

  Podium Presenter: JJ Zhang, MD
• 2:20 PM – 2:30 PM CST

  PD21-10: Patient and Geographic Factors Associated with Early Adoption of Tissue-Based Genomic Testing for Prostate Cancer
  

  Podium Presenter: Manuel Armas-Phan
• 2:30 PM – 2:40 PM CST

  PD21-11: REAL WORLD IMPACT OF GERMLINE GENETIC TESTING ON CLINICAL DECISION MAKING FOR PROSTATE CANCER PATIENTS
  

  Podium Presenter: Neal D. Shore, MD (he/him/his)